Catalyst Clinical Research Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Catalyst Clinical Research's estimated annual revenue is currently $153M per year.(i)
  • Catalyst Clinical Research's estimated revenue per employee is $201,000

Employee Data

  • Catalyst Clinical Research has 761 Employees.(i)
  • Catalyst Clinical Research grew their employee count by 9% last year.

Catalyst Clinical Research's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Executive Director, Business DevelopmentReveal Email/Phone
4
VP, StrategyReveal Email/Phone
5
Data Protection OfficerReveal Email/Phone
6
VP, Oncology Drug DevelopmentReveal Email/Phone
7
VP, Clinical Development OperationsReveal Email/Phone
8
VP Finance and AdministrationReveal Email/Phone
9
SVP, Strategy and SolutionsReveal Email/Phone
10
VP Project ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$333.4M215113%N/AN/A
#2
$235.6M1172-3%N/AN/A
Add Company

What Is Catalyst Clinical Research?

At Catalyst, our focus is to advance Biopharmaceutical, Device and Clinical Research Organizations'? development programs by providing flexible, customized, and cost effective research services comprised of targeted, seasoned and therapeutically-aligned expertise. From the engagement of a single clinical research professional to an entire clinical team, Catalyst is industry known as the proven and trusted outsourcing choice.

keywords:N/A

N/A

Total Funding

761

Number of Employees

$153M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Catalyst Clinical Research News

2022-04-17 - Moleculin obtains FDA clearance for Phase I glioma treatment ...

Moleculin Biotech is all set to commence Phase I clinical trial of ... Catalyst Clinical Research to conduct clinical trial of Annamycin,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$248.7M77924%N/A
#2
$316M8363%N/A
#3
$525M84511%N/A
#4
$222.5M88336%N/A
#5
$222.5M88336%N/A